Shantee Anaquod, a 23-year-old battling a rare disease, has been approved to receive coverage for Soliris, a $750,000 drug that until yesterday was not covered in B.C.
This story was originally published on CBC News. To read the rest of this news worthy story, please visit http://www.cbc.ca/news/canada/british-columbia/ubc-student-with-rare-disease-first-in-b-c-to-be-approved-for-750k-drug-soliris-1.4412980?cmp=rss.